F.D.A. Expedites Review of New Uses for Xarelto, an Anticlotting Drug

July 10, 2012, 1:13 am by New York Times - Health

Johnson & Johnson, a developer of the drug, has asked the agency to approve Xarelto to treat deep vein thrombosis and pulmonary embolism.

Read the full article

More from New York Times - Health

Well: Mothers With Cancer
New York Times - Health : May 23, 2013, 12:33 pm
Children of mothers with cancer must learn this painful lesson early: the vulnerability of the figure on whom they have grounded their existence. With varying degrees of fearful awareness, such children intuit

Well: What’s in Your Green Tea?
New York Times - Health : May 23, 2013, 12:01 pm
A new report from ConsumerLab.com shows that some bottled varieties of green tea appear to be little more than sugar water, while some green tea leaves are contaminated with lead    

Well: Awareness: Heartburn Tied to Throat Cancer
New York Times - Health : May 23, 2013, 10:00 am
Frequent heartburn increases the risk for throat cancer, a new study has found, and over-the-counter antacids may provide protection.    

California Puts Tentative Price on Health Policies Under New Law
New York Times - Health : May 23, 2013, 9:49 am
Thirteen insurers had been chosen to sell policies through the insurance marketplace — or exchange — being created under the law.    

Doctor and Patient: Doctors Ill Prepared for Patients With Disabilities
New York Times - Health : May 23, 2013, 3:56 am
Nearly 23 years after the Americans With Disabilities Act went into effect, patients with disabilities continue to receive inadequate medical care — and many cannot even get a doctor’s appointment.